Lucera Erick Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$29,199.04
Insider Sells Quantity
2
Insider Sells Sum
$132,434.07

Insider Activity of Lucera Erick

According to the SEC Form 4 filings, Lucera Erick, being in a position of

  1. Chief Financial Officer at Dyne Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11334 shares for $228,676,
    over all time since 2026-04-01, has bought 0 shares, and sold 11334 shares for $228,676.

Biography of Lucera Erick

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$228,6764100

Comparison of Insiders on Amount of Buys and Sells

2026-08-13SaleDyne Therapeutics, Inc.
DYN
Chief Financial Officer
1,797
0.0011%
$26.28$47,225-34.09%
2026-06-25SaleDyne Therapeutics, Inc.
DYN
Chief Financial Officer
2,362
0.0014%
$20.37$48,114+10.24%
2026-05-13SaleDyne Therapeutics, Inc.
DYN
Chief Financial Officer
1,448
0.0009%
$18.36$26,585+1.3%
2026-04-01SaleDyne Therapeutics, Inc.
DYN
Chief Financial Officer
5,727
0.0036%
$18.64$106,751+2.54%
2025-03-04SaleEditas Medicine, Inc.
EDIT
EVP, CHIEF FINANCIAL OFFICER
4,109
0.0048%
$1.71$7,030+25.57%
2024-08-14PurchaseBeyond Air, Inc.
XAIR
director
39,266
0.0764%
$0.40$15,565-16.25%
2024-05-20SaleEditas Medicine, Inc.
EDIT
EVP, CHIEF FINANCIAL OFFICER
22,337
0.0276%
$5.61$125,404-50.82%
2023-03-16PurchaseBeyond Air, Inc.
XAIR
director
2,000
0.0067%
$6.82$13,634-59.29%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.